Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format

Journal of Clinical Microbiology

Volumn 34, Issue 5, 1996, Pages 1232-1234

  Vasquez, A ^a   Valdez, Y ^a   Gilman, R H ^a,b,f   McDonald, J J ^c   Westblom, T U ^d   Berg, D ^e   Mayta, H ^a   Gutierrez, V ^a   Berendson, Robert ^a   Leon Barua, Raul ^a   Ramirez Ramos, Alberto ^a   Recavarren Arce, Sixto ^a   Watanabe, Jose ^g  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d University School of Medicine   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g Secretario General de la Asociación Peruana para el estudio del Hígado Unidad de Hígado del Policlínico Peruano Japonés   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CHRONIC GASTRITIS; CLINICAL ARTICLE; DUODENUM ULCER; DYSPEPSIA; HELICOBACTER PYLORI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; REPRODUCIBILITY; STOMACH CANCER; STRAIN DIFFERENCE;

EID: 9244264392     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.5.1232-1234.1996     Document Type: Article

References (17)

1. Berger, S., A. Gorea, M. Moskowitz, M. Santo, and T. Gilat. 1993 Effects of inoculum size on antimicrobial susceptibility of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 12:782-783.
2. De Boer, W., W. Driessen, A. Jansz, and G. Tytgat. 1995. Effect of acid suppression on efficacy of treatment for Melicobacter pylori infection. Lancet 345:817-820.
3. DeCross, A., B. Marshall, R. McCallum, S. Hoffman, L. Barrett, and R. Guerrant. 1993. Metronidazole susceptibility testing for Helicobacter pylori disk, broth, and agar dilution methods and their clinical relevance. J Clin. Microbiol 31:1971-1974
4. Gilman, R., R. Leon-Barua, A. Ramirez-Ramos, S. Recavarren, and J. Cok. 1990. High recurrence of Helicobacter pylori infection after triple therapy with amoxicillin, bismuth subsalicilate, and tinidazol, vol. III, p. 233-238. In Proceedings of the 3rd Tokyo International Symposium on Campylobacter pylori, Tokyo.
5. 4a.Hanstein, D. (PRISMA, Lima, Peru). Personal communication.
6. León-Barúa, R., S. Recavaren, R. Gilman, and R. Berendson. 1993. Can eradication of Helicobacter pylori prevent gastric cancer? Drugs 46:341-346.
7. Malanoski, G. J., G. M. Eliopoulos, M. J. Ferraro, and R. C. Moellering. 1993. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolides antimicrobial agents and temafloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 12:131-133
8. Mégraud, F. 1993. H. pylori resistance to antibiotics, p. 570-583. In Helicobacter pylori: basic mechanisms to clinical cure. Kluwer Academic Publishers, Boston
9. Noach, L. A., W. L. Langenberg, M. A. Bertola, J. Dankert, and G. N. Tytgat. 1994. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand. J. Infect. Dis. 26:321-327.
10. Nomura, A., G. Stemmerman, P. Chyou, I. Kato, and G. Perez-Perez. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med 325:1132-1136.
11. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131
12. Queiroz, D., E. Mendes, and G. Rocha. 1987 Indicator medium for isolation of Campylobacter pylori. J. Clin. Microbiol. 25:2378-2379.
13. Sanchez, M., and R. Jones. 1993. E Test, an antimicrobial susceptibility testing method with broad clinical and epidemiologic application. Antimicrob. Newsl. 8:1-8.
14. Seppala, K., M. Farkkila, H. Nuutinen, K. Hakala, and H. Vaananen. 1992. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12 month follow-up of 93 patients. Scand. J. Gastroenterol. 27:973-976.
15. Tytgat, G., L. Noach, and E. Rauws. 1993. Helicobacter pylori infection and duodenal ulcer disease Gastroenterol. Clin North Am. 22:127-139.
16. Tytgat, G., and L. Noach. 1993. H. pylori eradication, p. 550-569. In Helicobacter pylori: basic mechanisms to clinical cure. Kluwer Academic Publishers, Boston.
17. Westblom, T., E. Madan, and B. Midkiff. 1991. Egg yolk emulsion against a new medium for the cultivation of Helicobacter pylori J. Clin. Microbiol 29:819-821.